Mirae Asset Global Investments Co., Ltd. Innoviva, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Innoviva, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,864 shares of INVA stock, worth $36,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,864
Previous 29,194
93.62%
Holding current value
$36,422
Previous $444,000
93.24%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INVA
# of Institutions
222Shares Held
79.7MCall Options Held
20KPut Options Held
5.4K-
Black Rock Inc. New York, NY9.63MShares$188 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$142 Million20.14% of portfolio
-
Franklin Resources Inc San Mateo, CA6.62MShares$129 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$123 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$121 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.36B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...